Release and Harm Reduction International’s written submission to the Department of Health and Social Care (DHSC)'s September 2021 Consultation on expanding access to naloxone. The submission is in response to the DHSC's proposed amending of the Human Medicines Regulations 2012 so that certain services other than drug treatment services can supply naloxone to individuals without a prescription (and supplied other than at a registered pharmacy premises).